Steve Kitchen

Plasma D‐dimer levels and their relationship to serum fibrinogen/fibrin degradation products in hypercoagulable states

M. Greaves, S. Kitchen, S. Kinsey, 1989, British journal of haematology.

Anti Xa Monitoring during Treatment with Low Molecular Weight Heparin or Danaparoid: Inter-assay Variability

S. Kitchen, F. E. Preston, A. Woolley, 1999, Thrombosis and Haemostasis.

Optimizing warfarin reversal – an ex vivo study

M. Makris, E. Tuddenham, A. Gatt, 2009, Journal of thrombosis and haemostasis : JTH.

The Therapeutic Range for Heparin Therapy: Relationship between Six Activated Partial Thromboplastin Time Reagents and Two Heparin Assays

S. Kitchen, F. Preston, Steve Kitchen, 1996, Thrombosis and Haemostasis.

Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience.

R. Reynolds, D. Arachchillage, T. Devey, 2016, Thrombosis research.

Limitation of the activated partial thromboplastin time as a monitoring method of the direct thrombin inhibitor argatroban

S. Kitchen, R. Maclean, J. V. van Veen, 2015, International journal of laboratory hematology.

Argatroban is stable in citrated whole blood for 24 hours

S. Kitchen, J. V. van Veen, S. Guy, 2018, International journal of laboratory hematology.

Von Willebrand factor activity assay errors

A. Bowyer, M. F. Shepherd, Steve Kitchen, 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

The investigation of a prolonged APTT with specific clotting factor assays is unnecessary if an APTT with Actin FS is normal

R. Maclean, A. Bowyer, A. Woolley, 2011, International journal of laboratory hematology.